Paul Hamberg

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Clinical Trials : A Methodologic Perspective 1997 Steven Piantadosi
1
+ Dose-escalation models for combination phase I trials in oncology 2010 Paul Hamberg
Mark J. Ratain
Emmanuel Lesaffre
Jaap Verweij
1
+ Cancer phase I clinical trials: efficient dose escalation with overdose control 1998 James S. Babb
André Rogatko
Shelemyahu Zacks
1
+ A note on the robustness of the continual reassessment method 2012 David Azriel
1
+ A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents 2008 Guosheng Yin
Ying Yuan
1
+ Design and Analysis of Phase I Clinical Trials 1989 Barry E. Storer
1
+ PDF Chat Comparison of Outcomes of Phase II Studies and Subsequent Randomized Control Studies Using Identical Chemotherapeutic Regimens 2005 Mohammad I. Zia
Lillian L. Siu
Gregory R. Pond
Eric X. Chen
1
+ Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer 1990 John O’Quigley
Margaret S. Pepe
Lloyd D. Fisher
1
+ A Generalization of the Probit and Logit Methods for Dose Response Curves 1976 Ross L. Prentice
1
+ PDF Chat Continual reassessment designs with early termination 2002 John O’Quigley
1
+ PDF Chat Dose Escalation Methods in Phase I Cancer Clinical Trials 2009 Christophe Le Tourneau
J. Jack Lee
Lillian L. Siu
1
+ PDF Chat Phase I Studies of Drug Combinations 2010 Jaap Verweij
Mary L. Disis
Stephen A. Cannistra
1
+ Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer Agents 1993 Mark J. Ratain
Rosemarie Mick
Richard L. Schilsky
Mark Siegler
1
+ PDF Chat Phase I Drug Combination Trial Design: Walking the Tightrope 2009 Paul Hamberg
Jaap Verweij
1
+ PDF Chat Translation of Innovative Designs Into Phase I Trials 2007 André Rogatko
David J. Schoeneck
William Jonas
Mourad Tighiouart
Fadlo R. Khuri
Alan L. Porter
1
+ Bayesian adaptive clinical trials: a dream for statisticians only? 2011 Sylvie Chevret
1
+ PDF Chat Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities 2000 Ying Kuen Cheung
Rick Chappell
1